BSCL2 Antikörper (AA 263-354)
Kurzübersicht für BSCL2 Antikörper (AA 263-354) (ABIN1327730)
Target
Alle BSCL2 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 263-354
-
Verwendungszweck
- Mouse polyclonal antibody raised against a partial recombinant BSCL2.
-
Sequenz
- WPRHRFSLQV NIRKRDNSRK EVQRRISAHQ PGPEGQEEST PQSDVTEDGE SPEDPSGTEG QLSEEEKPDQ QPLSGEEELE PEASDGSGSW ED
-
Kreuzreaktivität
- Human
-
Produktmerkmale
- Antibody Reactive Against Recombinant Protein.
-
Immunogen
- BSCL2 (NP_116056, 263 a.a. ~ 354 a.a) partial recombinant protein with GST tag.
-
-
-
-
Applikationshinweise
- Optimal working dilution should be determined by the investigator.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Buffer
- 50 % glycerol
-
Handhabung
- Aliquot to avoid repeated freezing and thawing.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- Store at -20°C or lower. Aliquot to avoid repeated freezing and thawing.
-
-
-
: "Adipose-specific knockout of SEIPIN/BSCL2 results in progressive lipodystrophy." in: Diabetes, Vol. 63, Issue 7, pp. 2320-31, (2014) (PubMed).
: "Overexpression of a short human seipin/BSCL2 isoform in mouse adipose tissue results in mild lipodystrophy." in: American journal of physiology. Endocrinology and metabolism, Vol. 302, Issue 6, pp. E705-13, (2012) (PubMed).
-
-
- BSCL2 (Berardinelli-Seip Congenital Lipodystrophy 2 (Seipin) (BSCL2))
-
Andere Bezeichnung
- BSCL2
-
Hintergrund
-
Full Gene Name: Bernardinelli-Seip congenital lipodystrophy 2 (seipin)
Synonyms: GNG3LG,HMN5,MGC4694,SPG17 -
Gen-ID
- 26580
-
NCBI Accession
- NM_032667
Target
-